Despite cannabis still being classified as a Schedule I controlled substance under federal law, recent legislative changes have paved the way for limited cannabis trademarks in the United States.
Holon Law Partners represents Mr. Lucas Sirois in the District of Maine, (USA v. SIROIS et al) where significant issues arise from the unique context of the regulated and licensed cannabis industry. This case is not just about marijuana; it’s about holding the government accountable for its actions and ensuring that it operates with integrity and honesty. We are determined to stand firm against this injustice.
As many in the cannabis industry know, one of the rallying cries of the cannabis decriminalization and legalization movement has been that cannabis (marijuana) use is not as harmful as was once believed, and in fact is largely safe and can even be therapeutic for some.
Vice President Kamala Harris recently announced a groundbreaking plan for the federal legalization of cannabis, signaling a potential turning point for the industry and advocates across the country.
The hemp beverage market is evolving rapidly, presenting both opportunities and challenges.
Smoke shops selling flavored vapes have become sitting ducks for Food and Drug Administration (“FDA”) enforcement, protected only by their sheer numbers and the FDA’s inability to enforce against every individual retailer across 50 states.
The popularity of ketamine as a potential treatment for mental health issues such as depression, anxiety, post-traumatic stress disorder (PTSD), and obsessive-compulsive disorder has exploded in recent years. Unlike marijuana and other psychedelics such as psilocybin and MDMA, ketamine is an FDA-approved drug. However, the use of ketamine to treat […]
The federal PACT Act may significantly impact the online sale of cannabis and hemp vapes, requiring rigorous compliance with registration, reporting, age verification, and shipping regulations. For online retailers, understanding and adhering to these requirements is crucial in order to avoid a run-in with federal authorities.
President Joe Biden’s decision to withdraw from the 2024 presidential race and endorse Vice President Kamala Harris has sent ripples through various sectors of American business. One area where this change in leadership could have a profound impact is the future of cannabis legislation in the United States.
While the burgeoning and ever-evolving hemp-derived THC food market offers lucrative opportunities, entering this new market requires serious consideration of the various regulatory hurdles at early stages in product development.